Literature DB >> 30877580

A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027.

José A Bauermeister1, Jesse M Golinkoff2, Alex Carballo-Diéguez3,4, Rebecca Giguere3, Daniela López5, Craig J Hoesley6, Beatrice A Chen7,8, Peter Anderson9, Charlene S Dezzutti7,8, Julie Strizki10, Carol Sprinkle11, Faye Heard6, Wayne Hall8, Cindy Jacobson8, Jennifer Berthiaume12, Ashley Mayo13, Barbra A Richardson12, Jeanna Piper14.   

Abstract

Intravaginal rings (IVR) containing antiretroviral drugs are a promising method for HIV prevention. We triangulated quantitative and qualitative assessments to evaluate the acceptability of four IVRs used continuously for 28 days as part of a Phase I trial (N = 48 HIV-negative women; ages 18-45). Adherence was high throughout the trial, yet 30% of participants reported involuntary IVR expulsions followed by re-insertion. Most participants (93.6%) felt comfortable with the IVR being inside their body. Participants reported liking the IVR more (36.2%) or the same amount (55.3%) since starting the study. When given the option of choosing between the IVR and/or a male condom for HIV-prevention, most reported preferring the IVR (n = 29, 63.0%), and over a quarter of the sample reported liking them equally (n = 12, 26.1%). We observed no differences in IVR acceptability across the study arms. High adherence and acceptability underscores the promise of an IVR as a female-controlled, sustained mechanism for HIV prevention.

Entities:  

Keywords:  HIV prevention; Microbicide; Vaginal ring; Women

Mesh:

Substances:

Year:  2020        PMID: 30877580      PMCID: PMC6745293          DOI: 10.1007/s10461-019-02457-0

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  28 in total

1.  High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women.

Authors:  A van der Straten; E T Montgomery; H Cheng; L Wegner; G Masenga; C von Mollendorf; L Bekker; S Ganesh; K Young; J Romano; A Nel; C Woodsong
Journal:  AIDS Behav       Date:  2012-10

2.  Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results.

Authors:  Elizabeth T Montgomery; Jonathan Stadler; Sarita Naidoo; Ariana W K Katz; Nicole Laborde; Morgan Garcia; Krishnaveni Reddy; Leila E Mansoor; Juliane Etima; Chifundo Zimba; Miria Chitukuta; Lydia Soto-Torres
Journal:  AIDS       Date:  2018-07-17       Impact factor: 4.177

3.  Women and HIV. Microbicides for HIV prevention.

Authors:  Anna Forbes
Journal:  BETA       Date:  2006

Review 4.  Microbicide acceptability research: current approaches and future directions.

Authors:  Joanne E Mantell; Landon Myer; Alex Carballo-Diéguez; Zena Stein; Gita Ramjee; Neetha S Morar; Polly F Harrison
Journal:  Soc Sci Med       Date:  2005-01       Impact factor: 4.634

5.  Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women.

Authors:  Beatrice A Chen; Jingyang Zhang; Holly M Gundacker; Craig W Hendrix; Craig J Hoesley; Robert A Salata; Charlene S Dezzutti; Ariane van der Straten; Wayne B Hall; Cindy E Jacobson; Sherri Johnson; Ian McGowan; Annalene M Nel; Lydia Soto-Torres; Mark A Marzinke
Journal:  Clin Infect Dis       Date:  2019-03-19       Impact factor: 9.079

Review 6.  Microbicides for HIV prevention: reality or hope?

Authors:  Ian McGowan
Journal:  Curr Opin Infect Dis       Date:  2010-02       Impact factor: 4.915

7.  Delivery of microbicides to the vagina: difficulties reported with the use of three devices, adherence to use and preferences.

Authors:  Ellen Hardy; Eliana M Hebling; Maria H Sousa; Anecy F Almeida; Eliana Amaral
Journal:  Contraception       Date:  2007-06-27       Impact factor: 3.375

8.  Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women.

Authors:  Annalene Nel; Neliëtte van Niekerk; Saidi Kapiga; Linda-Gail Bekker; Cynthia Gama; Katherine Gill; Anatoli Kamali; Philip Kotze; Cheryl Louw; Zonke Mabude; Nokuthula Miti; Sylvia Kusemererwa; Hugo Tempelman; Hannelie Carstens; Brid Devlin; Michelle Isaacs; Mariëtte Malherbe; Winel Mans; Jeremy Nuttall; Marisa Russell; Smangaliso Ntshele; Marlie Smit; Leonard Solai; Patrick Spence; John Steytler; Kathleen Windle; Maarten Borremans; Sophie Resseler; Jens Van Roey; Wim Parys; Tony Vangeneugden; Ben Van Baelen; Zeda Rosenberg
Journal:  N Engl J Med       Date:  2016-12-01       Impact factor: 91.245

Review 9.  Microbicide vaginal rings: Technological challenges and clinical development.

Authors:  R Karl Malcolm; Peter J Boyd; Clare F McCoy; Diarmaid J Murphy
Journal:  Adv Drug Deliv Rev       Date:  2016-01-30       Impact factor: 15.470

10.  The importance of male partner involvement for women's acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe.

Authors:  Elizabeth T Montgomery; Ariane van der Straten; Agnes Chidanyika; Tsungai Chipato; Shabbar Jaffar; Nancy Padian
Journal:  AIDS Behav       Date:  2011-07
View more
  4 in total

1.  Users' Preferred Characteristics of Vaginal Rings for HIV Prevention: A Qualitative Analysis of Two Phase I Trials.

Authors:  Imogen Hawley; Mei Song; Rachel Scheckter; Tara McClure; Jeanna Piper; Beatrice A Chen; Craig Hoesley; Albert Y Liu; Ariane van der Straten
Journal:  AIDS Res Hum Retroviruses       Date:  2022-02-11       Impact factor: 1.723

2.  Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world.

Authors:  Kathleen Ridgeway; Elizabeth T Montgomery; Kevin Smith; Kristine Torjesen; Ariane van der Straten; Sharon L Achilles; Jennifer B Griffin
Journal:  Contraception       Date:  2021-10-10       Impact factor: 3.051

3.  Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial.

Authors:  Sarah T Roberts; Imogen Hawley; Ellen Luecke; Barbara Mensch; Theresa Wagner; Craig Hoesley; Tara McClure; Clara P Dominguez Islas; Jeanna M Piper; Albert Y Liu; Ariane van der Straten
Journal:  J Womens Health (Larchmt)       Date:  2021-10-19       Impact factor: 3.017

Review 4.  Topical delivery of long-acting antiretrovirals to prevent HIV acquisition.

Authors:  Thesla Palanee-Phillips; Jared M Baeten
Journal:  Curr Opin HIV AIDS       Date:  2020-01       Impact factor: 4.061

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.